154 related articles for article (PubMed ID: 37948373)
21. Radiomic Analysis Reveals Prognostic Information in T1-Weighted Baseline Magnetic Resonance Imaging in Patients With Glioblastoma.
Ingrisch M; Schneider MJ; Nörenberg D; Negrao de Figueiredo G; Maier-Hein K; Suchorska B; Schüller U; Albert N; Brückmann H; Reiser M; Tonn JC; Ertl-Wagner B
Invest Radiol; 2017 Jun; 52(6):360-366. PubMed ID: 28079702
[TBL] [Abstract][Full Text] [Related]
22. Machine learning-based radiomic, clinical and semantic feature analysis for predicting overall survival and MGMT promoter methylation status in patients with glioblastoma.
Lu Y; Patel M; Natarajan K; Ughratdar I; Sanghera P; Jena R; Watts C; Sawlani V
Magn Reson Imaging; 2020 Dec; 74():161-170. PubMed ID: 32980505
[TBL] [Abstract][Full Text] [Related]
23. A radiomics-based model to differentiate glioblastoma from solitary brain metastases.
Su CQ; Chen XT; Duan SF; Zhang JX; You YP; Lu SS; Hong XN
Clin Radiol; 2021 Aug; 76(8):629.e11-629.e18. PubMed ID: 34092362
[TBL] [Abstract][Full Text] [Related]
24. Primary central nervous system lymphoma and atypical glioblastoma: Differentiation using radiomics approach.
Suh HB; Choi YS; Bae S; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK
Eur Radiol; 2018 Sep; 28(9):3832-3839. PubMed ID: 29626238
[TBL] [Abstract][Full Text] [Related]
25. MRI Features May Predict Molecular Features of Glioblastoma in
Park CJ; Han K; Kim H; Ahn SS; Choi D; Park YW; Chang JH; Kim SH; Cha S; Lee SK
AJNR Am J Neuroradiol; 2021 Mar; 42(3):448-456. PubMed ID: 33509914
[TBL] [Abstract][Full Text] [Related]
26. Radiomic Features on Multiparametric MRI for Preoperative Evaluation of Pituitary Macroadenomas Consistency: Preliminary Findings.
Wan T; Wu C; Meng M; Liu T; Li C; Ma J; Qin Z
J Magn Reson Imaging; 2022 May; 55(5):1491-1503. PubMed ID: 34549842
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of tumor-derived MRI-texture features for discrimination of molecular subtypes and prediction of 12-month survival status in glioblastoma.
Yang D; Rao G; Martinez J; Veeraraghavan A; Rao A
Med Phys; 2015 Nov; 42(11):6725-35. PubMed ID: 26520762
[TBL] [Abstract][Full Text] [Related]
28. Machine-learning based radiogenomics analysis of MRI features and metagenes in glioblastoma multiforme patients with different survival time.
Liao X; Cai B; Tian B; Luo Y; Song W; Li Y
J Cell Mol Med; 2019 Jun; 23(6):4375-4385. PubMed ID: 31001929
[TBL] [Abstract][Full Text] [Related]
29. Radiogenomic-Based Survival Risk Stratification of Tumor Habitat on Gd-T1w MRI Is Associated with Biological Processes in Glioblastoma.
Beig N; Bera K; Prasanna P; Antunes J; Correa R; Singh S; Saeed Bamashmos A; Ismail M; Braman N; Verma R; Hill VB; Statsevych V; Ahluwalia MS; Varadan V; Madabhushi A; Tiwari P
Clin Cancer Res; 2020 Apr; 26(8):1866-1876. PubMed ID: 32079590
[TBL] [Abstract][Full Text] [Related]
30. Machine learning-based Radiomics analysis for differentiation degree and lymphatic node metastasis of extrahepatic cholangiocarcinoma.
Tang Y; Yang CM; Su S; Wang WJ; Fan LP; Shu J
BMC Cancer; 2021 Nov; 21(1):1268. PubMed ID: 34819043
[TBL] [Abstract][Full Text] [Related]
31. Differentiation of recurrent glioblastoma from radiation necrosis using diffusion radiomics with machine learning model development and external validation.
Park YW; Choi D; Park JE; Ahn SS; Kim H; Chang JH; Kim SH; Kim HS; Lee SK
Sci Rep; 2021 Feb; 11(1):2913. PubMed ID: 33536499
[TBL] [Abstract][Full Text] [Related]
32. Sexually dimorphic radiogenomic models identify distinct imaging and biological pathways that are prognostic of overall survival in glioblastoma.
Beig N; Singh S; Bera K; Prasanna P; Singh G; Chen J; Saeed Bamashmos A; Barnett A; Hunter K; Statsevych V; Hill VB; Varadan V; Madabhushi A; Ahluwalia MS; Tiwari P
Neuro Oncol; 2021 Feb; 23(2):251-263. PubMed ID: 33068415
[TBL] [Abstract][Full Text] [Related]
33. Novel Radiomic Features Based on Joint Intensity Matrices for Predicting Glioblastoma Patient Survival Time.
Chaddad A; Daniel P; Desrosiers C; Toews M; Abdulkarim B
IEEE J Biomed Health Inform; 2019 Mar; 23(2):795-804. PubMed ID: 29993848
[TBL] [Abstract][Full Text] [Related]
34. [Application of MRI-based Radiomics Models in the Assessment of Hepatic Metastasis of Rectal Cancer].
Hu SX; Yang K; Wang XR; Wen DG; Xia CC; Li X; Li ZL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Mar; 52(2):311-318. PubMed ID: 33829708
[TBL] [Abstract][Full Text] [Related]
35. Differentiating Glioblastoma Multiforme from Brain Metastases Using Multidimensional Radiomics Features Derived from MRI and Multiple Machine Learning Models.
Bijari S; Jahanbakhshi A; Hajishafiezahramini P; Abdolmaleki P
Biomed Res Int; 2022; 2022():2016006. PubMed ID: 36212721
[TBL] [Abstract][Full Text] [Related]
36. Multiregional radiomics profiling from multiparametric MRI: Identifying an imaging predictor of IDH1 mutation status in glioblastoma.
Li ZC; Bai H; Sun Q; Zhao Y; Lv Y; Zhou J; Liang C; Chen Y; Liang D; Zheng H
Cancer Med; 2018 Dec; 7(12):5999-6009. PubMed ID: 30426720
[TBL] [Abstract][Full Text] [Related]
37. Differentiation between glioblastoma, brain metastasis and subtypes using radiomics analysis.
Artzi M; Bressler I; Ben Bashat D
J Magn Reson Imaging; 2019 Aug; 50(2):519-528. PubMed ID: 30635952
[TBL] [Abstract][Full Text] [Related]
38. MRI texture features as biomarkers to predict MGMT methylation status in glioblastomas.
Korfiatis P; Kline TL; Coufalova L; Lachance DH; Parney IF; Carter RE; Buckner JC; Erickson BJ
Med Phys; 2016 Jun; 43(6):2835-2844. PubMed ID: 27277032
[TBL] [Abstract][Full Text] [Related]
39. Improving Noninvasive Classification of Molecular Subtypes of Adult Gliomas With Diffusion-Weighted MR Imaging: An Externally Validated Machine Learning Algorithm.
Guo Y; Ma Z; Pei D; Duan W; Guo Y; Liu Z; Guan F; Wang Z; Xing A; Guo Z; Luo L; Wang W; Yu B; Zhou J; Ji Y; Yan D; Cheng J; Liu X; Yan J; Zhang Z
J Magn Reson Imaging; 2023 Oct; 58(4):1234-1242. PubMed ID: 36727433
[TBL] [Abstract][Full Text] [Related]
40. Integrative analysis of diffusion-weighted MRI and genomic data to inform treatment of glioblastoma.
Jajamovich GH; Valiathan CR; Cristescu R; Somayajula S
J Neurooncol; 2016 Sep; 129(2):289-300. PubMed ID: 27393347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]